Project Details
| Status | Active |
|---|---|
| Effective start/end date | 4/27/22 → 4/27/25 |
Funding
- Clinipace, Inc. (Prot #ADCT-901-101)
- ADC Therapeutics Sarl (Prot #ADCT-901-101)
Prot #ADCT-901-101: A Phase 1, Open-Label, Dose-Escalation and Dose-Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ADCT-901 as Monotherapy in Patients With Selected Advanced Solid Tumors
- Mahalingam, Devalingam (PD/PI)
Project: Research project